These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25066792)

  • 21. Use of psychiatric medications in schizophrenia and other psychoses in a general population sample.
    Nykänen S; Puska V; Tolonen JP; Salo H; Isohanni M; Koponen H; Pirkola S; Penttilä M; Haapea M; Moilanen J; Miettunen J; Jääskeläinen E
    Psychiatry Res; 2016 Jan; 235():160-8. PubMed ID: 26652841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.
    Harrow M; Jobe TH
    J Nerv Ment Dis; 2007 May; 195(5):406-14. PubMed ID: 17502806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis.
    Iyo M; Tadokoro S; Kanahara N; Hashimoto T; Niitsu T; Watanabe H; Hashimoto K
    J Clin Psychopharmacol; 2013 Jun; 33(3):398-404. PubMed ID: 23609386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial.
    Clausen L; Hjorthøj CR; Thorup A; Jeppesen P; Petersen L; Bertelsen M; Nordentoft M
    Psychol Med; 2014 Jan; 44(1):117-26. PubMed ID: 23590927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are antipsychotic prescribing patterns different in older and younger adults?: a survey of 1357 psychiatric inpatients in Toronto.
    Sproule BA; Lake J; Mamo DC; Uchida H; Mulsant BH
    Can J Psychiatry; 2010 Apr; 55(4):248-54. PubMed ID: 20416148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
    Lecardeur L; Meunier-Cussac S; Dollfus S
    Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 20-year multi-follow-up of hallucinations in schizophrenia, other psychotic, and mood disorders.
    Goghari VM; Harrow M; Grossman LS; Rosen C
    Psychol Med; 2013 Jun; 43(6):1151-60. PubMed ID: 23034091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefits of atypical antipsychotic medications in the treatment of psychosis.
    White DL
    Kans Nurse; 2003; 78(10):1-2. PubMed ID: 14746070
    [No Abstract]   [Full Text] [Related]  

  • 30. [RÉALITÉ LT, a pharmacoepidemiological study of semiology and therapeutic strategy of patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice].
    Cousin FR; Samuelian JC; Saoud M; Schmitt L; Vacheron MN; Vidailhet P; Augendre J; Walter M; Tonelli I; Pascal JC
    Encephale; 2012 Feb; 38(1):64-74. PubMed ID: 22381726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: a 2 year observational study.
    Nyakyoma K; Morriss R
    Psychopharmacol Bull; 2010; 43(2):67-81. PubMed ID: 21052043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex, ethnicity, and antipsychotic medication use in patients with psychosis.
    Arnold LM; Strakowski SM; Schwiers ML; Amicone J; Fleck DE; Corey KB; Farrow JE
    Schizophr Res; 2004 Feb; 66(2-3):169-75. PubMed ID: 15061250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basal ganglia volumetric changes in psychotic spectrum disorders.
    Liu C; Cao B; Yu R; Sim K
    J Affect Disord; 2019 Aug; 255():150-157. PubMed ID: 31153051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features.
    Craig TJ; Grossman S; Mojtabai R; Gibson PJ; Lavelle J; Carlson GA; Bromet EJ
    Bipolar Disord; 2004 Oct; 6(5):406-15. PubMed ID: 15383133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Society for Neuroscience--36th Annual Meeting: Therapeutic advances for psychosis and affective disorders.
    Croydon L
    IDrugs; 2006 Dec; 9(12):815-8. PubMed ID: 17139563
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: a longitudinal MRI study.
    Nicolo JP; Berger GE; Garner BA; Velakoulis D; Markulev C; Kerr M; McGorry PD; Proffitt TM; McConchie M; Pantelis C; Wood SJ
    Schizophr Res; 2010 Jan; 116(1):49-54. PubMed ID: 19896337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
    Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ
    JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
    Kelly AC; Sheitman BB; Hamer RM; Rhyne DC; Reed RM; Graham KA; Rau SW; Gilmore JH; Perkins DO; Peebles SS; VanderZwaag CJ; Jarskog LF
    J Clin Psychopharmacol; 2014 Aug; 34(4):441-5. PubMed ID: 24943389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.